Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan · Delayed Price · Currency is TWD 37.25
-0.70 (-1.84%)
At close: Jul 9, 2026
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 4.9 billion as of July 9, 2026. Its market cap has decreased by -15.04% in one year.
Market Cap
4.90B
Enterprise Value
4.15B
Revenue
69.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
37.25
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 4.90B, an increase of 0.91%. That is a compound annual growth rate of 0.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 4.90B | -26.82% |
| Dec 31, 2025 | 6.70B | -1.89% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
| Feb 22, 2022 | 4.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 6.42B |
| Sinphar Pharmaceutical | 6.40B |
| TWi Biotechnology | 5.53B |
| Mycenax Biotech | 5.48B |
| UnicoCell Biomed | 5.42B |
| Medigen Biotechnology | 5.33B |
| Steminent Biotherapeutics | 4.92B |
| Sinew Pharma | 4.71B |